Physician profile
Amy Elizabeth Gee
NPI 1891318036
$3,976.82
in general payments reported to CMS, 2019-2025
18 companies · $3,269 in 2025
The $3,269 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.09 · 2022: $195 · 2023: $321 · 2024: $149 · 2025: $3,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,063 · Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,062.50 |
| Food and Beverage | $676.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,296.73 | 2022-2025 | |
| Argenx US, INC. | $185.53 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Horizon Therapeutics Plc | $114.57 | 2023 | Uplizna |
| Teva Pharmaceuticals USA, INC. | $74.74 | 2022-2024 | Ajovy, Austedo |
| Lundbeck LLC | $63.24 | 2022-2025 | Vyepti |
| Sunovion Pharmaceuticals INC. | $48.12 | 2022 | |
| Corium, LLC | $26.29 | 2023 | Adlarity |
| Amneal Pharmaceuticals LLC | $26.22 | 2023 | Rytary |
| Lilly USA, LLC | $16.56 | 2023 | Amyvid |
| Sk Life Science, INC. | $16.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.52 | 2021 | |
| Acorda Therapeutics, INC | $15.10 | 2023 | Inbrija |
| Tg Therapeutics, INC. | $14.77 | 2025 | |
| Pfizer INC. | $14.31 | 2023 | |
| Livanova USA, INC. | $14.01 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $11.92 | 2022 | |
| Amgen INC. | $11.62 | 2022 | |
| Acadia Pharmaceuticals INC | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Gee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.